A scam involving Solana wallets uses lookalike blockchain addresses to trick users into sending funds to attackers. The scam starts with a small test transfer followed by a large payment to a fake address that closely resembles the legitimate one, exploiting shortened wallet displays. Over 4.4 million wallets were exposed between late 2025 and late 2026, with at least 1,104 wallets confirmed to have sent nearly $940,000 to these lookalike addresses. Users are advised to verify full addresses carefully and avoid copying from transaction histories to prevent losses.
The Solana wallet scam exposed over 4.4 million wallets to fraudulent lookalike addresses. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Oct 12, 2026 17:41 WIB: out of 50 major cryptocurrencies, 37 rose and 12 fell today. Notable movers include FIL (Filecoin) up 13.65% at Rp22.153 with a typical hold time of 99 days and a Pluang order activity skewed 78% Sell / 22% Buy, BAL (Balancer) up 11.14% at Rp16.297 with an 85-day hold time, and ALGO (Algorand) up 8.54% at Rp2.312 with a 130-day hold time and 42% Sell / 58% Buy order activity.
Harmony Biosciences announced that Peter Anastasiou will become President and CEO effective January 1, 2027, succeeding Jeffrey M. Dayno, who will retire at the end of 2026. Dayno will remain as a non-executive advisor through 2027 to support the com...
Zenas BioPharma presented new data on obexelimab at the 6th International Symposium on IgG4-Related Disease, highlighting sustained clinical activity in treating IgG4-RD. Phase 3 INDIGO open-label extension results showed a high probability of patien...
The St. Louis Blues and Gray Media announced a multi-year deal to broadcast 10 select Thursday games over-the-air on ABC 32 in St. Louis and 10 other markets during the 2026-27 NHL season. This expands access to Blues games for over 4.8 million house...
Fate Therapeutics has appointed Jamie Harrell as Senior Vice President of Market Development & Commercial Operations to spearhead the commercialization of its CAR T-cell therapies, including FT819 and FT839, targeting autoimmune diseases like lupus n...
Iridex Corporation announced a two-year clinical study demonstrating that MicroPulse transscleral laser therapy significantly reduces intraocular pressure (IOP) and medication use in patients with early to advanced glaucoma. The study, involving 84 e...
